跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,256 条关于
“interleukin-17A inhibitors”
全部
17,256
临床试验
8,508
药物
3,904
机构
10
资讯
4,834
10个月前
Guselkumab Shows Superior Treatment Persistence Over IL-17A Inhibitors in Psoriatic Arthritis Study
6年前
Immunology Market Evolution: Interleukin Inhibitors Rise as Biosimilars Reshape Treatment Landscape
去年
Bimzelx Approved by FDA as First IL-17A and IL-17F Inhibitor for Hidradenitis Suppurativa
去年
FDA Approves UCB's Bimzelx (bimekizumab-bkzx) for Hidradenitis Suppurativa
去年
Bimekizumab Approved by FDA for Moderate to Severe Hidradenitis Suppurativa
去年
FDA Approves Bimzelx (bimekizumab) as First IL-17A/F Inhibitor for Hidradenitis Suppurativa
去年
Tocilizumab Investigated for Acute Myocardial Infarction with Cardiogenic Shock
去年
Junshi Biosciences' IL-17A Inhibitor JS005 Meets Primary Endpoints in Phase 3 Psoriasis Trial
6个月前
FDA Approves Cosentyx for Pediatric Hidradenitis Suppurativa, Marking First IL-17A Inhibitor for Adolescents
2个月前
Study Links Oxalate to Systemic Inflammation and Heart Damage via IL-17A Pathway in Kidney Disease
第 1 页,共 484 页
上一页
下一页